Shasha Hu

2.4k total citations · 2 hit papers
39 papers, 1.6k citations indexed

About

Shasha Hu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Shasha Hu has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Surgery and 7 papers in Oncology. Recurrent topics in Shasha Hu's work include Cancer-related molecular mechanisms research (4 papers), Cancer-related Molecular Pathways (3 papers) and Case Reports on Hematomas (3 papers). Shasha Hu is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Cancer-related Molecular Pathways (3 papers) and Case Reports on Hematomas (3 papers). Shasha Hu collaborates with scholars based in China, United States and United Kingdom. Shasha Hu's co-authors include Jianjun Gao, Liying Dong, Zhengdong Guo, Dong Wang, Jian Yang, Siyuan Zhang, Yangyang Bian, Peng Lei, Xiaoqian Liu and Jiangling Yao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Hepatology.

In The Last Decade

Shasha Hu

32 papers receiving 1.6k citations

Hit Papers

Discovering drugs to treat coronavirus disease 2019 (COVI... 2020 2026 2022 2024 2020 2022 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Discovering drugs to treat coronavirus disease 2019 (COVID-19)
    2020 991 citations Shasha Hu et al. profile →
  2. Targeting Cell Death: Pyroptosis, Ferroptosis, Apoptosis and Necroptosis in Osteoarthritis
    2022 174 citations Jian Yang, Shasha Hu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shasha Hu China 15 755 513 246 213 145 39 1.6k
Andrés López‐Cortés Ecuador 22 640 0.8× 712 1.4× 239 1.0× 127 0.6× 138 1.0× 104 2.0k
Jie Sheng China 16 1.4k 1.8× 622 1.2× 170 0.7× 223 1.0× 162 1.1× 41 2.2k
Donghong Yang China 16 558 0.7× 397 0.8× 153 0.6× 258 1.2× 56 0.4× 51 1.4k
Yung‐Hung Luo Taiwan 16 552 0.7× 427 0.8× 247 1.0× 158 0.7× 85 0.6× 61 1.4k
Yunfei Lu China 19 546 0.7× 391 0.8× 194 0.8× 223 1.0× 67 0.5× 45 1.4k
Xiaofang Zhao China 19 909 1.2× 488 1.0× 231 0.9× 267 1.3× 59 0.4× 58 2.2k
Hui Guo China 22 767 1.0× 677 1.3× 250 1.0× 178 0.8× 247 1.7× 93 2.0k
Ling Zhang United States 18 673 0.9× 403 0.8× 92 0.4× 188 0.9× 76 0.5× 113 1.8k
Yunjiao Zhou China 15 573 0.8× 390 0.8× 106 0.4× 223 1.0× 50 0.3× 27 1.3k
Manman Geng China 12 885 1.2× 330 0.6× 97 0.4× 300 1.4× 52 0.4× 19 1.5k

Countries citing papers authored by Shasha Hu

Since Specialization
Citations

This map shows the geographic impact of Shasha Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shasha Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shasha Hu more than expected).

Fields of papers citing papers by Shasha Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shasha Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shasha Hu. The network helps show where Shasha Hu may publish in the future.

Co-authorship network of co-authors of Shasha Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Shasha Hu. A scholar is included among the top collaborators of Shasha Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shasha Hu. Shasha Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Li, et al.. (2025). Identification and functional analysis of J-domain proteins involved in determining flowering time in Phalaenopsis orchids. Plant Physiology and Biochemistry. 226. 110081–110081.
2.
3.
Li, Guangqi, et al.. (2024). Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high‐grade transformation from differentiated thyroid carcinoma. The Journal of Pathology Clinical Research. 10(2). e356–e356. 8 indexed citations
4.
Yan, Bing, et al.. (2023). Spermidine protects intestinal mucosal barrier function in mice colitis via the AhR/Nrf2 and AhR/STAT3 signaling pathways. International Immunopharmacology. 119. 110166–110166. 22 indexed citations
5.
Hu, Shasha, et al.. (2023). Activation of the 5-hydroxytryptamine 4 receptor ameliorates tight junction barrier dysfunction in the colon of type 1 diabetic mice. Acta Biochimica et Biophysica Sinica. 55(12). 1874–1883. 1 indexed citations
6.
Yi, Xiaoli, et al.. (2023). Effect of HER2-low expression on neoadjuvant efficacy in operable breast cancer. Clinical & Translational Oncology. 26(4). 880–890. 5 indexed citations
7.
Hu, Shasha, Hui Chen, Lan Wang, et al.. (2023). SLC25A21 downregulation promotes KRAS-mutant colorectal cancer progression by increasing glutamine anaplerosis. JCI Insight. 8(21). 14 indexed citations
8.
Chen, Hui, Congrui Liao, Anran Xu, et al.. (2023). SEMA3B‐AS1 suppresses colorectal carcinoma progression by inhibiting Semaphorin 3B‐dependent VEGF signaling pathway activation. SHILAP Revista de lepidopterología. 4(5). e365–e365. 5 indexed citations
9.
Jiang, Li, et al.. (2023). Characterization of NF–Y gene family and their expression and interaction analysis in Phalaenopsis orchid. Plant Physiology and Biochemistry. 204. 108143–108143. 4 indexed citations
10.
Hu, Shasha, Shaowen Cheng, Yanyan Wang, et al.. (2022). A Large Cavernous Sinus Giant Cell Tumor Invading Clivus and Sphenoid Sinus Masquerading as Meningioma: A Case Report and Literature Review. Frontiers in Surgery. 9. 861739–861739. 1 indexed citations
11.
Wang, Yong, et al.. (2021). SLC25A21 Suppresses Cell Growth in Bladder Cancer via an Oxidative Stress-Mediated Mechanism. Frontiers in Oncology. 11. 682710–682710. 15 indexed citations
12.
Chen, Chaoyi, Liying Zhang, Ke Wang, et al.. (2020). Clinical study of preoperative psychological distress and its related factors in the primary caregivers of patients with glioma. Clinical Neurology and Neurosurgery. 200. 106364–106364. 7 indexed citations
13.
Lin, Dongliang, et al.. (2020). Extrapancreatic solid pseudopapillary neoplasm: report of a unique case of primary posterior mediastinum origin and review of the literature. Translational Cancer Research. 9(4). 3024–3029. 3 indexed citations
14.
Wang, Yiqing, Dongmei Jiang, Shasha Hu, et al.. (2019). SATB2-AS1 Suppresses Colorectal Carcinoma Aggressiveness by Inhibiting SATB2-Dependent Snail Transcription and Epithelial–Mesenchymal Transition. Cancer Research. 79(14). 3542–3556. 74 indexed citations
15.
Wang, Wei, Yanhua Yang, Xinyi Chen, et al.. (2019). MAGI1 mediates tumor metastasis through c-Myb/miR-520h/MAGI1 signaling pathway in renal cell carcinoma. APOPTOSIS. 24(11-12). 837–848. 12 indexed citations
16.
Wang, Tianxi, et al.. (2019). Low expression levels of plasma miR‑141 are associated with susceptibility to gastric cancer. Oncology Letters. 18(1). 629–636. 4 indexed citations
17.
Hu, Shasha, Yong Hou, Qian Wang, et al.. (2018). Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China. Arthritis Research & Therapy. 20(1). 235–235. 33 indexed citations
18.
Wang, Hao‐Wei, et al.. (2017). [Expression of cAMP-dependent protein kinase inhibitor beta in colorectal carcinoma and its clinical significance].. PubMed. 37(6). 744–749. 2 indexed citations
19.
20.
Pogam, Sophie Le, et al.. (2009). 958 NO EVIDENCE OF R7128 DRUG RESISTANCE AFTER UP TO 4 WEEKS TREATMENT OF GT 1, 2 AND 3 HEPATITIS C VIRUS INFECTED INDIVIDUALS. Journal of Hepatology. 50. S348–S348. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrés López‐Cortés Breakdown of academic impact, for papers by Jie Sheng Breakdown of academic impact, for papers by Donghong Yang Breakdown of academic impact, for papers by Yung‐Hung Luo Breakdown of academic impact, for papers by Yunfei Lu Breakdown of academic impact, for papers by Xiaofang Zhao Breakdown of academic impact, for papers by Hui Guo Breakdown of academic impact, for papers by Ling Zhang Breakdown of academic impact, for papers by Yunjiao Zhou Breakdown of academic impact, for papers by Manman Geng
Rankless by CCL
2026